Browsing by Author "Morgan, T."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settingsPeginterferon alfa-2a (40 KD) (pegasys) in combination with ribavirin (RBV): Efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose(Elsevier Science Bv, 2002)
;Hadziyannis, S. J. ;Cheinquer, H. ;Morgan, T. ;Diago, M. ;Jensen, D. M. ;Sette, H.; ;Bodenheimer, H. C. ;Marcellin, P. ;Lee, S. D. ;Roberts, P. J.Ackrill, A. M. - Some of the metrics are blocked by yourconsent settingsProspective evaluation of early virological response associated with 40 kDa peginterferon alfa-2a (PEGASYS (R)) plus ribavirin therapy from a phase III, randomized, double-blind study examining the effects of treatment duration and ribavirin dosing.(W B Saunders Co, 2001)
;Hadziyannis, S. J. ;Cheinquer, H. ;Morgan, T. ;Diago, M. ;Jensen, D. M. ;Sette, H.; ;Bodenheimer, H. C. ;Zarski, J. P. ;Lee, S. D. ;Roberts, P.Ackrill, A. M.